Page last updated: 2024-10-22

amlexanox and Malignant Melanoma

amlexanox has been researched along with Malignant Melanoma in 2 studies

amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.

Research Excerpts

ExcerptRelevanceReference
"In vivo, we applied a mouse melanoma skin cancer model to assess tumour growth and melanoma-associated pain in IKKε knockout mice as well as C57BL/6 mice after inoculation with IKKε-negative cells."1.43The protein kinase IKKepsilon contributes to tumour growth and tumour pain in a melanoma model. ( Geisslinger, G; King-Himmelreich, TS; Laarmann, K; Meissner, M; Möser, CV; Niederberger, E; Olbrich, K; Wolters, MC, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Möller, M1
Wasel, J1
Schmetzer, J1
Weiß, U1
Meissner, M2
Schiffmann, S1
Weigert, A1
Möser, CV2
Niederberger, E2
Laarmann, K1
Olbrich, K1
King-Himmelreich, TS1
Wolters, MC1
Geisslinger, G1

Other Studies

2 other studies available for amlexanox and Malignant Melanoma

ArticleYear
The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways.
    International journal of molecular sciences, 2020, Jul-02, Volume: 21, Issue:13

    Topics: Aminopyridines; Animals; Autophagy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; I-k

2020
The protein kinase IKKepsilon contributes to tumour growth and tumour pain in a melanoma model.
    Biochemical pharmacology, 2016, Mar-01, Volume: 103

    Topics: Aminopyridines; Animals; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; Humans; I-kapp

2016